The information at Drugs.com is not a substitute for medical advice. ALWAYS consult your doctor or pharmacist.
Usual Adult Dose for:
Additional dosage information:
Usual Adult Dose for Multiple Sclerosis
0.5 mg orally once daily
Comments: Monitor with first dose (see WARNINGS section).
Use: For the treatment of patients with relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disability.
Renal Dose Adjustments
No adjustment recommended
Liver Dose Adjustments
Mild to moderate hepatic impairment: No adjustment recommended.
Severe hepatic impairment: Closely monitor patients.
The US FDA requires a Risk Evaluation and Mitigation Strategy (REMS) for fingolimod. It includes a communication plan. Additional information is available at www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm111350.htm.
Safety and efficacy have not been established in patients younger than 18 years.
Consult WARNINGS section for additional precautions.
Data not available
-Take with or without food.
-Doses higher than 0.5 mg are associated with a greater incidence of adverse reactions without additional benefit.
Storage requirements: Store at room temperature in the original blister pack; protect from moisture.
More about fingolimod
- Other brands: Gilenya